• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中性粒细胞减少症患者经验性使用卡泊芬净治疗时出现突破性曲霉菌属aspergillata 感染。

Breakthrough Hormographiella aspergillata infections arising in neutropenic patients treated empirically with caspofungin.

机构信息

Université Paris Descartes, Service d'Hématologie Adultes, Hôpital Necker-Enfants Malades, AP-HP, 149 Rue de Sèvres, 75743 Paris Cedex 15, France.

出版信息

J Clin Microbiol. 2011 Jan;49(1):461-5. doi: 10.1128/JCM.01213-10. Epub 2010 Nov 10.

DOI:10.1128/JCM.01213-10
PMID:21068290
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3020423/
Abstract

Hormographiella aspergillata, a filamentous basidiomycete, has rarely been involved in human infections. We describe 2 febrile neutropenic patients who developed a severe pulmonary infection due to H. aspergillata while receiving empirical caspofungin therapy for presumed fungal pneumonia. After introduction of liposomal amphotericin B, one patient, who had neutrophil recovery, presented a favorable outcome, while the other, who remained neutropenic throughout the course of infection, died. Resistant fungi, including basidiomycetes, may emerge during empirical treatment with caspofungin in febrile neutropenic patients. A rapid switch to any other potent antifungal should be rapidly considered in case of failure of caspofungin in this setting.

摘要

aspergillata 是一种丝状担子菌,很少引起人类感染。我们描述了 2 例发热性中性粒细胞减少症患者,他们在接受经验性卡泊芬净治疗疑似真菌性肺炎时,因感染 H. aspergillata 而发生严重肺部感染。在使用脂质体两性霉素 B 后,1 例中性粒细胞恢复的患者结果良好,而另 1 例在整个感染过程中持续中性粒细胞减少的患者则死亡。在发热性中性粒细胞减少症患者中,经验性使用卡泊芬净可能会出现耐药真菌,包括担子菌。在这种情况下,如果卡泊芬净治疗失败,应迅速考虑快速切换为任何其他强效抗真菌药物。

相似文献

1
Breakthrough Hormographiella aspergillata infections arising in neutropenic patients treated empirically with caspofungin.中性粒细胞减少症患者经验性使用卡泊芬净治疗时出现突破性曲霉菌属aspergillata 感染。
J Clin Microbiol. 2011 Jan;49(1):461-5. doi: 10.1128/JCM.01213-10. Epub 2010 Nov 10.
2
Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.脂质体两性霉素B:关于其在发热性中性粒细胞减少症经验性治疗及侵袭性真菌感染治疗中应用的综述
Drugs. 2009;69(3):361-92. doi: 10.2165/00003495-200969030-00010.
3
An open study of the comparative efficacy and safety of caspofungin and liposomal amphotericin B in treating invasive fungal infections or febrile neutropenia in patients with haematological malignancy.一项关于卡泊芬净与脂质体两性霉素B治疗血液系统恶性肿瘤患者侵袭性真菌感染或发热性中性粒细胞减少症的疗效及安全性比较的开放性研究。
J Med Microbiol. 2006 Oct;55(Pt 10):1357-1365. doi: 10.1099/jmm.0.46452-0.
4
Economic evaluation of caspofungin versus liposomal amphotericin B for empiric antifungal treatment in patients with neutropenic fever in Italy.意大利中性粒细胞减少性发热患者经验性抗真菌治疗中卡泊芬净与两性霉素B脂质体的经济学评价
Value Health. 2008 Sep-Oct;11(5):830-41. doi: 10.1111/j.1524-4733.2008.00324.x. Epub 2008 May 20.
5
Caspofungin versus liposomal amphotericin B: are they really comparable?卡泊芬净与两性霉素B脂质体:它们真的具有可比性吗?
Pediatr Infect Dis J. 2010 Oct;29(10):985-6; author reply 986-7. doi: 10.1097/INF.0b013e3181f2d878.
6
Combined medico-surgical strategy for invasive sino-orbito-cerebral breakthrough fungal infection with Hormographiella aspergillata in an acute leukaemia patient.急性白血病患者侵袭性鼻窦-眼眶-脑突破型曲霉感染的综合药物-手术治疗策略
Mycoses. 2015 May;58(5):308-12. doi: 10.1111/myc.12305. Epub 2015 Mar 6.
7
Economic impact of caspofungin as compared with liposomal amphotericin B for empirical therapy in febrile neutropenia in Australia.在澳大利亚,卡泊芬净与脂质体两性霉素B用于发热性中性粒细胞减少症经验性治疗的经济影响比较
J Antimicrob Chemother. 2009 Jun;63(6):1276-85. doi: 10.1093/jac/dkp119. Epub 2009 Apr 3.
8
Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.卡泊芬净与两性霉素B脂质体用于持续发热和中性粒细胞减少患者的经验性抗真菌治疗比较
N Engl J Med. 2004 Sep 30;351(14):1391-402. doi: 10.1056/NEJMoa040446.
9
A prospective, randomized study of empirical antifungal therapy for the treatment of chemotherapy-induced febrile neutropenia in children.一项针对儿童化疗引起的发热性中性粒细胞减少症进行经验性抗真菌治疗的前瞻性、随机研究。
Br J Haematol. 2012 Jul;158(2):249-255. doi: 10.1111/j.1365-2141.2012.09156.x. Epub 2012 May 10.
10
A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia.一项卡泊芬净与两性霉素 B 脂质体用于儿童持续性发热伴中性粒细胞减少症经验性抗真菌治疗的随机、双盲、多中心研究。
Pediatr Infect Dis J. 2010 May;29(5):415-20. doi: 10.1097/INF.0b013e3181da2171.

引用本文的文献

1
(1, 3)-beta-D-Glucan in bronchoalveolar lavage fluid: a useful biomarker in diagnosis of invasive pulmonary infection caused by Hormographiella aspergillata?支气管肺泡灌洗液中的(1, 3)-β-D-葡聚糖:侵袭性曲霉感染诊断中的有用生物标志物?
Diagn Pathol. 2024 Dec 28;19(1):168. doi: 10.1186/s13000-024-01589-9.
2
Breakthrough Invasive Sinusitis by Hormographiella aspergillata in a Neutropenic Patient Receiving Voriconazole Therapy: A Case Report and Review of Breakthrough H. aspergillata Infections.中性粒细胞减少症患者接受伏立康唑治疗时被aspergillata 型霍氏曲霉引起的侵袭性鼻窦突破:病例报告和对霍氏曲霉突破感染的回顾。
Mycopathologia. 2023 Aug;188(4):401-407. doi: 10.1007/s11046-023-00768-4. Epub 2023 Jun 30.
3
The first suspected disseminated infection in China, diagnosed using metagenomic next-generation sequencing: a case report and literature review.中国首例采用宏基因组二代测序诊断的疑似播散性感染:病例报告及文献复习。
Emerg Microbes Infect. 2023 Dec;12(1):2220581. doi: 10.1080/22221751.2023.2220581.
4
Successful Treatment of Rare Pulmonary Infection in a 17-Year-Old Female After Hematopoietic Stem Cell Transplantation: A Case Report.造血干细胞移植后一名17岁女性罕见肺部感染的成功治疗:一例报告
Infect Drug Resist. 2023 Mar 18;16:1567-1572. doi: 10.2147/IDR.S397233. eCollection 2023.
5
Invasive Infection Identified Using DNA Sequencing.使用DNA测序鉴定侵袭性感染
Ann Lab Med. 2022 May 1;42(3):370-372. doi: 10.3343/alm.2022.42.3.370.
6
Invasive infection in patients with acute myeloid leukemia: Report of two cases successfully treated and review of the literature.急性髓系白血病患者的侵袭性感染:两例成功治疗病例报告及文献复习
Med Mycol Case Rep. 2021 Apr 14;32:68-72. doi: 10.1016/j.mmcr.2021.03.008. eCollection 2021 Jun.
7
Hormographiella aspergillata: an emerging basidiomycete in the clinical setting? A case report and literature review.地舌菌属:临床环境中的新兴担子菌?病例报告及文献复习。
BMC Infect Dis. 2020 Dec 11;20(1):945. doi: 10.1186/s12879-020-05679-z.
8
Nebulized Liposomal Amphotericin B for Treatment of Pulmonary Infection Caused by Hormographiella aspergillata: Case Report and Literature Review.雾化脂质体两性霉素B治疗烟曲霉所致肺部感染:病例报告及文献复习
Mycopathologia. 2017 Aug;182(7-8):709-713. doi: 10.1007/s11046-017-0117-9. Epub 2017 Jan 31.
9
Filamentous Basidiomycetes in the Clinical Laboratory.临床实验室中的丝状担子菌
Curr Fungal Infect Rep. 2013 Sep;7(3):219-223. doi: 10.1007/s12281-013-0148-8. Epub 2013 Jul 13.
10
On and Under the Skin: Emerging Basidiomycetous Yeast Infections Caused by Trichosporon Species.皮肤表面及皮下:由毛孢子菌属引起的新兴担子菌酵母菌感染
PLoS Pathog. 2015 Jul 30;11(7):e1004982. doi: 10.1371/journal.ppat.1004982. eCollection 2015 Jul.

本文引用的文献

1
Hormographiella aspergillata: an emerging mould in acute leukaemia patients?曲霉样枝孢菌:急性白血病患者的一种新出现的霉菌?
Clin Microbiol Infect. 2011 Feb;17(2):273-7. doi: 10.1111/j.1469-0691.2010.03266.x.
2
What lurks in the sellar?蝶鞍内隐藏着什么?
Lancet. 2010 Jan 30;375(9712):432. doi: 10.1016/S0140-6736(09)61835-3.
3
Overall survival and fungal infection-related mortality in patients with invasive fungal infection and neutropenia after myelosuppressive chemotherapy in a tertiary care centre from 1995 to 2006.1995 年至 2006 年,在一家三级保健中心接受骨髓抑制性化疗后患有侵袭性真菌感染和中性粒细胞减少的患者的总体生存率和真菌感染相关死亡率。
J Antimicrob Chemother. 2010 Apr;65(4):761-8. doi: 10.1093/jac/dkp507. Epub 2010 Jan 27.
4
Rhizomucor variabilis var. regularior and Hormographiella aspergillata infections in a leukemic bone marrow transplant recipient with refractory neutropenia.变枝毛霉及其变异变种和aspergillata 感染在一位患有难治性中性粒细胞减少症的白血病骨髓移植受者中。
J Clin Microbiol. 2009 Dec;47(12):4176-9. doi: 10.1128/JCM.00305-09. Epub 2009 Oct 21.
5
New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.新型三唑类和棘白菌素类药物:作用模式、体外活性和耐药机制。
Expert Rev Anti Infect Ther. 2009 Oct;7(8):981-98. doi: 10.1586/eri.09.67.
6
Increasing incidence of zygomycosis (mucormycosis), France, 1997-2006.法国 1997-2006 年接合菌病(毛霉病)发病率上升。
Emerg Infect Dis. 2009 Sep;15(9):1395-401. doi: 10.3201/eid1509.090334.
7
Case of fatal Blastoschizomyces capitatus infection occurring in a patient receiving empiric micafungin therapy.患者接受经验性米卡芬净治疗时发生致命荚膜组织胞浆菌感染病例报告。
Antimicrob Agents Chemother. 2009 Dec;53(12):5306-7. doi: 10.1128/AAC.00710-09. Epub 2009 Sep 8.
8
A Multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis.一项针对成年侵袭性念珠菌病患者的高剂量卡泊芬净治疗方案与标准卡泊芬净治疗方案的多中心双盲试验。
Clin Infect Dis. 2009 Jun 15;48(12):1676-84. doi: 10.1086/598933.
9
Aspergillus PCR formidable challenges and progress.曲霉属聚合酶链反应面临的巨大挑战与进展。
Med Mycol. 2009;47 Suppl 1:S241-7. doi: 10.1080/13693780802616823. Epub 2009 Feb 27.
10
Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds.米卡芬净对西班牙常见和新出现的酵母及霉菌临床分离株的体外活性研究。
Antimicrob Agents Chemother. 2009 May;53(5):2192-5. doi: 10.1128/AAC.01543-08. Epub 2009 Feb 17.